Camille Perrin
6 Papers
5 Citations
Camille Perrin is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)
Camille Moreau-Bachelard,Loïc Campion,Maud Toulmonde,Axel Le Cesne,Mehdi Brahmi,Antoine Italiano,Olivier Mir,Sophie Piperno-Neumann,Valérie Laurence,Nelly Firmin,Nicolas Penel,Florence Duffaud,Christine Chevreau,François Bertucci,Bérengère Narciso,P. Dubray-Longeras,Corinne Delcambre,Esma Saada-Bouzid,Pascaline Boudou-Rouquette,Patrick Soulié,Camille Perrin,J.-Y. Blay,Emmanuelle Bompas +22 more
TL;DR: In this article , the outcomes, prognostic factors, and treatment of patients with metastatic synovial sarcoma (SS) within a nationwide cohort were described, and comparative analyses were conducted using SAS 9.4 and Stata Special Edition 16.1 software.
10
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.
J.-Y. Blay,Sophie Piperno-Neumann,S. Watson,A. Dufresne,Thibaud Valentin,Florence Duffaud,Maud Toulmonde,Antoine Italiano,François Bertucci,Camille Tlemsani,Nelly Firmin,Emmanuelle Bompas,Camille Perrin,Mickaël Ropars,Esma Saada-Bouzid,P. Dubray-Longeras,Alice Hervieu,Céleste Lebbé,Justine Gantzer,Loic Chaigneau,F. Fiorenza,Maria Rios,Nicolas Isambert,Pauline Soibinet,P. Boudou-Roquette,Benjamin Verret,G. Ferron,Thomas Ryckewaert,Loïc Lebellec,Mehdi Brahmi,François Gouin,Pierre Meeus,Gualter Vaz,F. le Loarer,Marie Karanian,Gonzague de Pinieux,Françoise Ducimetière,Claire Chemin,Maxime Morelle,Axel Le Cesne,Nicholas Penel +40 more
TL;DR: It is shown in a nationwide series over 12 years that most patients progressed but are still alive at 10 years, both in localised and metastatic stages.
10
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study
Axel Le Cesne,Christine Chevreau,Camille Perrin,Antoine Italiano,Alice Hervieu,J.-Y. Blay,Sophie Piperno-Neumann,Esma Saada-Bouzid,François Bertucci,Nelly Firmin,Elsa Kalbacher,Bérengère Narciso,Camille Schiffler,S. Yara,Marta Jimenez,Corine Bouvier,Vincent Vidal,Sebastien Chabaud,Florence Duffaud +18 more
TL;DR: In this article , regorafenib (160 mg/day, 21/28 days) or placebo was used to treat patients with advanced bone sarcomas and the primary endpoint was the progression-free rate at 6 months (PFR-6).
8
Liver Transplantation for Acute Liver Failure Attributed to Leptospirosis: A Report of Two Cases.
TL;DR: Antibiotic treatment for leptospirosis should not be delayed by the lack of a positive serology test for this potentially lethal disease, because of the severity of the associated acute liver failure.
1316O Improved nationwide survival of sarcoma patients 10 years after establishment of the NETSARC+ reference center network
J.-Y. Blay,Auxologico Italiano,Nicolas Penel,Emmanuelle Bompas,Florence Duffaud,Christine Chevreau,Philippe Anract,Camille Perrin,Nelly Firmin,Maud Toulmonde,Sophie Piperno-Neumann,Susanne Watson,Maria Rios,Jean-Emmanuel Kurtz,François Bertucci,François Le Loarer,Claire Chemin,Maxime Morelle,François Gouin,Axel Le Cesne +19 more
TL;DR: In this paper , the authors report on the nationwide impact of the NETSARC+ network on sarcoma survival since 2010 in France and show that treatment of sarcomas within networks of reference center is associated with improved outcome.
3